The antimicrobial activity of lapachol and its thiosemicarbazone and semicarbazone derivatives

Memorias do Instituto Oswaldo Cruz

Volumn 108, Issue 3, 2013, Pages 342-351

  Souza, Marina Azevêdo ^a   Johann, Susana ^a,b   dos Santos Lima, Luciana Alves Rodrigues ^c   Campos, Fernanda Fraga ^a,b   Mendes, Isolda Castro ^b   Beraldo, Heloisa ^b   de Souza Fagundes, Elaine Maria ^b   Silva Cisalpino, Patrícia ^b   Augusto Rosa, Carlos ^b   de Almeida Alves, Tânia Maria ^a   de Sá, Nívea Pereira ^b   Zani, Carlos Leomar ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO JOÃO DEL REI   (Brazil)

Author keywords

Antimicrobial agents; Lapachol; Paracoccidioides

Indexed keywords

EID: 84877289059     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762013000300013     Document Type: Article

References (41)

1. Almeida ER 2009. Preclinical and clinical studies of lapachol and beta-lapachone. The Open Natural Products Journal 2: 42-47.
2. Araújo EL, Alencar JRB, Rolim Neto PJ 2002. Lapachol: segurança e eficácia na terapêutica. Rev Bras Farmacogn 12: 57-59.
3. Beraldo H 2004. Semicarbazonas e tiossemicarbazonas: o amplo perfil farmacológico e usos clínicos. Quim Nova 27: 461-471.
4. Beraldo H, Lima R, Teixeira LR, Moura AA, West DX 2001. Crystal structures and IR, NMR and UV spectra of 4-formyl and 4-acetylpyridine N(4)-methyl and N(4)-ethylthiosemicarbazones. J Mol Struct 559: 99-106.
5. Brummer E, Castaneda E, Restrepo A 1993. Paracoccidioidomycosis: an update. Clin Microbiol Rev 6: 89-117.
6. Chaturvedi S, Dyavaiah M, Larsen RA, Chaturvedi V 2005. Cryptococcus gattii in AIDS patients, southern California. Emerg Infect Dis 11: 1686-1692.
7. Chikate RC, Belapure AR, Padhye SB, West DX 2005. Transition metal quinone-thiosemicarbazone complexes 1: evaluation of EPR covalency parameters and redox properties of pseudo-square-planar copper (II)-naphthoquinone thiosemicarbazones. Polyhedron 24: 889-899.
8. CLSI - Clinical and Laboratory Standards Institute 2008. Reference method for broth dilution antifungal susceptibility testing of yeast. Approved Standard M27-A3, CLSI, Wayne, 25 pp.
9. Coutinho ZF, Silva D, Lazera M, Petri V, Oliveira RM 2002. Paracoccidioidomycosis mortality in Brazil (1980-1995). Cad Saude Publica 18: 1441-1454.
10. Escalante A, Gattuso M, Pérez P, Zacchino S 2008. Evidence for the mechanism of action of the antifungal phytolaccoside B isolated from Phytolacca tetrâmera Hauman. J Nat Prod 71: 1720-1725.
11. Farrugia LJ 1997. ORTEP-3 for Windows - a version of ORTEP-III with a graphical user interface (GUI). J Appl Crystallogr 30: 565.
12. Farrugia LJ, Win GX 1999. Suite for single crystal small molecule crystallography. J Appl Crystallogr 32: 837.
13. Fluit AC, Verhoef J, Schmitz FJ 2001. Frequency of isolation and antimicrobial resistance of gram-negative and gram-positive bacteria from patients in intensive care units of 25 European university hospitals participating in the European arm of the SENTRY Antimicrobial Surveillance Program 1997-1998. Eur J Clin Microbiol Infect Dis 20: 617-625.
14. Fonseca SGC, Braga RMC, Santana DP 2003. Lapachol: chemistry, pharmacology and assay methods. Rev Bras Farm 84: 9-16.
15. Frost D, Brandt K, Cugier D 1995. A whole-cell Candida albicans assay for the detection of inhibitors towards fungal cell wall synthesis and assembly. J Antibiot (Tokyo) 48: 306-310.
16. Gafner S, Wolfender JL, Nianga M, Stoeckli-Evans H, Hostettmann K 1996. Antifungal and antibacterial naphthoquinones from Newbouldia laevis roots. Phytochemistry 42: 1315-1320.
17. Gazzinelli G, Katz N, Rocha RS, Colley DG 1983. Immune responses during human schistosomiasis mansoni. X. Production and standardization of an antigen-induced mitogenic activity by peripheral blood mononuclear cells from treated, but not active cases of schistosomiasis. J Immunol 130: 2891-2895.
18. Hahn RC, Hamdan JS 2000. Effects of amphotericin B and three azole derivatives on the lipids of yeast cells of Paracoccidioides brasiliensis. Antimicrob Agents Chemother 44: 1997-2000.
19. Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, Pollock DA, Fridkin SK, National Healthcare Safety Network Team, Participating National Healthcare Safety Network Facilities 2008. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 29: 996-1011.
20. Hoffman GH 2009. A perspective on the scientific, philosophical and policy dimensions of hormesis. Dose Response 7: 1-51.
21. Johnson CK 1965. ORTEP-I Report ORNL-3794, Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA.
22. Jones KE, Patel NG, Levy MA, Storeygard A, Balk D, Gittleman JL, Daszak P 2008. Global trends in emerging infectious diseases. Nature 451: 990-993.
23. Júnior ENS, Pinto MCFR, Moura KCG, Simone CA, Nascimento CJ, Andrade CKZ, Hooker's PAV 2009. Lapachol peroxide' revisited. Tetrahedron Lett 50: 1575-1577.
24. Lessa JA, Mendes IC, da Silva PR, Soares MA, dos Santos RG, Speziali NL, Romeiro NC, Barreiro EJ, Beraldo H 2010. 2-Acetylpyridine thiosemicarbazones: cytotoxic activity in nanomolar doses against malignant gliomas. Eur J Med Chem 45: 5671-5677.
25. Lima OG, Weigert E 1972. Atividade antimicrobiana e antineoplásica de juglona, lapachol e plumbagina. Rev Ints Antibiot 12: 3-12.
26. McBride SM, Fischetti VA, LeBlanc DJ, Moellering Jr RC, Gilmore MS 2007. Genetic diversity among Enterococcus faecalis. PLoS ONE 2: e582.
27. Mosmann T 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63.
28. Nagata K, Hirai KI, Koyama J, Wada Y, Tamura T 1998. Antimicrobial activity of novel furanonaphthoquinone analogs. Atimicrob Agents Chemother 42: 700-702.
29. NCCLS - National Committee for Clinical Laboratory Standards 2003. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, NCCLSI document M7-A6, 6th ed., NCCLS, Wayne, 53 pp.
30. Palazzo ICV, Araujo MLC, Darini ALC 2005. First report of vancomycin-resistant Staphylococci isolated from healthy carriers in Brazil. J Clin Microbiol 43: 179-185.
31. Paniago AMM, Aguiar JIA, Aguiar ES, Cunha RV, Pereira GROL, Londero AT, Wanke B 2003. Paracoccidioidomicose: estudo clínico e epidemiológico de 422 casos observados no estado de Mato Grosso do Sul. Rev Soc Bras Med Trop 36: 455-459.
32. Perfect JR, Casadevall A 2002. Cryptococcosis. Infect Dis Clin North Am 16: 837-874.
33. Rosenthal VD, Maki DG, Jamulitrat S, Medeiros EA, Todi SK, Gomez DY, Leblebicioglu H, Abu Khader I, Miranda Novales MG, Berba R, Ramírez Wong FM, Barkat A, Pino OR, Dueñas L, Mitrev Z, Bijie H, Gurskis V, Kanj SS, Mapp T, Hidalgo RF, Ben Jaballah N, Raka L, Gikas A, Ahmed A, Thu le TA, Guzmán Siritt ME, INICC Members 2010. International nosocomial infection control consortium report, data summary for 2002-2007, issued June 2009. Am J Infect Control 38: 95-104.
34. Sabbatani S, Manfredi R, Pavoni M, Consales A, Chiodo F 2004. Voriconazole proves effective in long-term treatment of a cerebral cryptococcoma in a chronic nephropathic HIV-negative patient, after fluconazole failure. Mycopathologia 158: 165-171.
35. Sheldrick GM 1997. SHELXL-97 - Program for Crystal Structure Refinement, University of Göttingen, Germany.
36. Travassos LR, Taborda CP, Colombo AL 2008. Treatment options for paracoccidioidomycosis and new strategies investigated. Expert Rev Anti Infect Ther 6: 251-262.
37. Vieira RP, Rocha L, Teixeira LR, Sinisterra RD, Coelho MM, Beraldo H 2010. Benzaldeído semicarbazona: um candidato a fármaco que alia simplicidade estrutural a um amplo perfil de atividades. Revista Virtual de Química 2: 2-9.
38. White TC, Marr KA, Bowden RA 1998. Clinical, cellular and molecular factors that contribute to antifungal drug resistance. Clin Microbiol Rev 11: 382-402.
39. Wills EA, Redinbo MR, Perfect JR, Poeta MD 2000. New potential targets for antifungal development. Expert Opin Ther Targets 4: 265-296.
40. Yang K, LeJeune J, Alsdorf D, Lu Bo, Shum CK, Liang S 2012. Global distribution of outbreaks of water-associated infectious diseases. PLoS Negl Trop Dis 6: e1483.
41. Zani C, Oliveira AB, Oliveira GG 1991. Furanonaphthoquinones from Tabebuia ochracea. Phytochemistry 30: 2379-2381.